Research Paper Volume 12, Issue 3 pp 2302—2332

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma

Figure 6. Expression of T-cell and immune checkpoint markers in low-risk and high-risk patients. Group differences were assessed by Wilcoxon test.